Preclinical development of SIG-007 for treatment of Fabry disease

被引：0
作者：
Fluharty, Brian [1 ]
Makino, Elina [1 ]
Donovan, Marissa [1 ]
Tietz, Drew [1 ]
Pearson, Erika [1 ]
Jansen, Lauren [1 ]
Barney, Lauren [1 ]
Sewell, Jared [1 ]
Huang, Janet [1 ]
Corzo, Deya [1 ]
Moller, David [1 ]
Peritt, David [1 ]
Vivaldi, Rogerio [1 ]
机构：
[1] Sigilon Therapeut, Cambridge, MA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2020年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2019.11.130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
121
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] THE CLINICAL DEVELOPMENT OF LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA
    Vanover, Kimberly
    Correll, Christoph
    Dmitrienko, Alex
    Glass, Steve
    O'Gorman, Cedric
    Saillard, Jelena
    Weingart, Michal
    Mates, Sharon
    Davis, Robert
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S16 - S16
  • [42] Ophthalmological manifestations of Fabry disease: A survey of patients at the Royal Melbourne Fabry Disease Treatment Centre
    Nguyen, TT
    Gin, T
    Nicholls, K
    Low, M
    Galanos, J
    Crawford, A
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (02) : 164 - 168
  • [43] PRECLINICAL DEVELOPMENT OF IMMUNOTHERAPIES FOR THE TREATMENT OF AIDS
    JOHNSTON, MI
    MCGOWAN, JJ
    ANTIVIRAL CHEMOTHERAPY : NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, VOL 2, 1989, : 357 - 366
  • [44] Preclinical development of agents for the treatment of osteoporosis
    Hartke, JR
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 143 - 147
  • [45] New drugs for the treatment of Anderson–Fabry disease
    Sandro Feriozzi
    Derralynn A. Hughes
    Journal of Nephrology, 2021, 34 : 221 - 230
  • [46] Agalsidase alfa: specific treatment for Fabry disease
    Mehta, A
    HOSPITAL MEDICINE, 2002, 63 (06): : 347 - 350
  • [47] Agalsidase treatment for Fabry disease: Uses and rivalries
    Schiffmann, Raphael
    GENETICS IN MEDICINE, 2010, 12 (11) : 684 - 685
  • [48] Strategy for treatment of Fabry disease after a stroke
    Torralba-Cabeza, Miguel A.
    Olivera-Gonzalez, Susana
    Josa-Laorden, Claudia
    Sierra, Jose L.
    Perez-Calvo, Juan I.
    REVISTA DE NEUROLOGIA, 2015, 60 (12) : 574 - 574
  • [49] What is confirmed in the treatment of Fabryʼs disease?
    Malte Lenders
    Eva Brand
    Die Innere Medizin, 2024, 65 (12) : 1188 - 1198
  • [50] Treatment of Fabry Disease: Established and Emerging Therapies
    Umer, Muhammad
    Kalra, Dinesh K. K.
    PHARMACEUTICALS, 2023, 16 (02)
12345